EMEA-001667-PIP01-14

Key facts

Active substance
abaloparatide
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0307/2014
PIP number
EMEA-001667-PIP01-14
Pharmaceutical form(s)
  • Solution for injection
  • Transdermal system
Condition(s) / indication(s)
Treatment of osteoporosis
Route(s) of administration
  • Subcutaneous use
  • Transdermal use
Contact for public enquiries
Triskel EU Services, Ltd (Jean-Yves le Cotonnec) 
United Kingdom 
E-mail: gwilliams@radiuspharm.com 
Tel. +1 6175514700
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating